Cyber Swan Sale

50% Off Elite

Days

Hours

Mins

Sec

Get our most powerful screeners, new charting tools, and the fastest ad-free experience at our best price ever. One last chance.

Open in Screener

OM

Outset Medical Inc

Dec 03 • 02:25PM ET

4.24

+0.19 4.69 %

Healthcare • Medical Devices • USA • NASD

Peers: FMS BAX PODD INSP RMD AXNX NARI NVRO OFIX MDXG

| Held by: VTI VXF IWM VTWO IWN IWO DFAS IWC ITOT FMED

Index	RUT	P/E	-	EPS (ttm)	-13.00	Insider Own	4.29%	Shs Outstand	17.81M	Perf Week	-5.15%
Market Cap	76.87M	Forward P/E	-	EPS next Y	-2.66	Insider Trans	-0.59%	Shs Float	17.37M	Perf Month	-67.41%
Enterprise Value	0.75M	PEG	-	EPS next Q	-0.68	Inst Own	98.80%	Short Float	12.07%	Perf Quarter	-68.24%
Income	-87.80M	P/S	0.64	EPS this Y	83.39%	Inst Trans	-0.13%	Short Ratio	5.18	Perf Half Y	-78.05%
Sales	120.07M	P/B	0.55	EPS next Y	40.36%	ROA	-30.80%	Short Interest	2.10M	Perf YTD	-74.53%
Book/sh	7.78	P/C	0.43	EPS next 5Y	55.29%	ROE	-92.33%	52W High	25.35 -83.27%	Perf Year	-68.46%
Cash/sh	9.85	P/FCF	-	EPS past 3/5Y	5.23% -4.06%	ROIC	-36.72%	52W Low	4.04 4.95%	Perf 3Y	-98.50%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	3.48% 49.79%	Gross Margin	37.74%	Volatility	6.35% 10.52%	Perf 5Y	-99.53%
Dividend TTM	-	EV/Sales	0.01	EPS Y/Y TTM	68.71%	Oper. Margin	-57.92%	ATR (14)	0.68	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.77	Sales Y/Y TTM	4.65%	Profit Margin	-73.12%	RSI (14)	21.34	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	7.09	EPS Q/Q	87.91%	SMA20	-31.25%	Beta	2.06	Target Price	15.75
Payout	-	Debt/Eq	0.69	Sales Q/Q	2.67%	SMA50	-61.27%	Rel Volume	0.85	Prev Close	4.05
Employees	-	LT Debt/Eq	0.68	Earnings	Nov 10 AMC	SMA200	-69.13%	Avg Volume	404.99K	Price	4.24
IPO	Sep 15, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.34% -4.23%	Trades		Volume	263,262	Change	4.69%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-08-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$6 → $3
Jun-21-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$5 → $6
Apr-08-24	Initiated	BTIG Research	Buy	$6
Apr-05-24	Upgrade	CL King	Neutral → Buy	$6
Jan-12-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$14 → $6
Oct-13-23	Downgrade	BofA Securities	Buy → Underperform	$32 → $3
Aug-17-23	Initiated	CL King	Neutral
Nov-11-22	Initiated	RBC Capital Mkts	Outperform	$23
Jul-14-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$48 → $20
Mar-02-22	Resumed	BofA Securities	Buy	$50
Feb-17-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$50
Aug-18-21	Initiated	Cowen	Outperform	$70
Apr-19-21	Initiated	Wells Fargo	Overweight	$63
Dec-16-20	Initiated	Oppenheimer	Perform
Oct-12-20	Initiated	SVB Leerink	Mkt Perform	$60
Oct-12-20	Initiated	Stifel	Buy	$54
Oct-12-20	Initiated	Morgan Stanley	Equal-Weight	$48
Oct-12-20	Initiated	Goldman	Buy	$54
Oct-12-20	Initiated	BofA Securities	Buy	$54
Oct-12-20	Initiated	Barclays	Overweight

Show Previous Ratings

Nov-11-25 12:02AM	Outset Medical Inc (OM) Q3 2025 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com) -48.47%
Nov-10-25 05:20PM	Outset Medical, Inc. (OM) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Outset Medical Reports Third-Quarter Results (GlobeNewswire)
Nov-07-25 07:23AM	Earnings To Watch: Outset Medical Inc (OM) Reports Q3 2025 Result (GuruFocus.com)
Nov-06-25 05:55PM	10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates (Zacks) -5.97%
04:05PM	Loading…
Nov-05-25 04:05PM	New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical's Tablo Hemodialysis System (GlobeNewswire)
09:00AM	Outset Medical to Present at the 2025 Stifel Healthcare Conference (GlobeNewswire)
Oct-27-25 04:05PM	Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025 (GlobeNewswire)
Sep-12-25 08:43AM	Tempus (TEM) Stock Jumps 13.6%: Will It Continue to Soar? (Zacks)
Sep-03-25 09:00AM	Northwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home Hemodialysis (GlobeNewswire)
Aug-20-25 04:05PM	Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-15-25 09:35AM	After Plunging 26.8% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical (OM) (Zacks)
Aug-06-25 05:55PM	Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates (Zacks) -6.60% +7.67%
04:02PM	Outset Medical Second-Quarter Results Demonstrate Continued Momentum, Punctuated by Strong Revenue Growth, Console Placements and Utilization (GlobeNewswire)
Aug-05-25 10:24AM	What To Expect From Outset Medical Inc (OM) Q2 2025 Earnings (GuruFocus.com)
06:05PM	Loading…
Aug-04-25 06:05PM	Inspire Medical Systems (INSP) Q2 Earnings and Revenues Surpass Estimates (Zacks) -5.85%
Jul-30-25 09:01AM	Outset Medical Names First Chief Nursing Officer (GlobeNewswire)
Jul-16-25 04:03PM	Outset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 (GlobeNewswire)
Jul-07-25 08:30AM	iRhythm Technologies Announces Board Member Retirements and New Director Appointments (GlobeNewswire)
Jun-25-25 07:59AM	Strength Seen in Outset Medical (OM): Can Its 15.0% Jump Turn into More Strength? (Zacks)
Jun-24-25 08:19AM	FMS Stock Likely to Gain on New Optimization Plan FME Reignite (Zacks) +14.97%
Jun-05-25 09:05AM	Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire)
Jun-03-25 04:30PM	Outset Medical Appoints Renee Gaeta as Chief Financial Officer (GlobeNewswire) +8.98%
May-29-25 05:04PM	Osisko Metals Announces Voting Results of Annual and Special Meeting of Shareholders (GlobeNewswire) -9.69%
May-14-25 09:00AM	Outset Medical Appoints Industry Veteran Kevin O'Boyle to its Board of Directors (GlobeNewswire) +7.31%
May-09-25 09:00AM	Outset Medical to Present at RBC Global Healthcare Conference (GlobeNewswire)
May-08-25 09:50AM	Q1 2025 Outset Medical Inc Earnings Call (Thomson Reuters StreetEvents) +35.26%
03:37AM	Outset Medical Inc (OM) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
May-07-25 09:30PM	Outset Medical, Inc. (OM) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:25PM	Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:02PM	Loading…
04:02PM	Outset Medical First-Quarter Results Demonstrate Strong Growth in Console and Recurring Revenue as Gross Margin Expanded and Cash Use Declined (GlobeNewswire)
May-05-25 07:00AM	Osisko Metals Intersects 323 Metres Averaging 0.43% Cu at Gaspe Project (GlobeNewswire)
May-01-25 06:25PM	American Well Corporation (AMWL) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +9.67%
Apr-21-25 09:55AM	Does Outset Medical (OM) Have the Potential to Rally 71.66% as Wall Street Analysts Expect? (Zacks) -9.36%
Apr-16-25 04:32PM	Outset Medical to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025 (GlobeNewswire)
10:38AM	Outset Medical: The Worst Is Over, But Execution Risk Remains High (Seeking Alpha)
05:00AM	90-Day Tariff Pause: Which Cryptocurrencies Should You Be Buying Now? (Motley Fool)
Apr-02-25 09:55AM	Wall Street Analysts Predict an 188.63% Upside in Outset Medical (OM): Here's What You Should Know (Zacks) +11.37%
Mar-21-25 06:35AM	Why Outset Medical Inc. (OM) Surged On Thursday? (InsiderMonkey) -10.90%
Mar-18-25 08:30AM	Outset Medical Announces One-for-Fifteen Reverse Stock Split (GlobeNewswire)
Feb-26-25 09:55AM	Bears are Losing Control Over Outset Medical (OM), Here's Why It's a 'Buy' Now (Zacks) -6.51%
Feb-24-25 04:03PM	Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference (GlobeNewswire) -6.82%
Feb-20-25 02:14PM	Q4 2024 Outset Medical Inc Earnings Call (Thomson Reuters StreetEvents)
02:13AM	Outset Medical Inc (OM) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... (GuruFocus.com)
Feb-19-25 05:15PM	Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:03PM	Outset Medical Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
05:00AM	Earnings To Watch: Outset Medical Inc (OM) Reports Q4 2024 Result (GuruFocus.com)
Feb-13-25 04:35PM	Outset Medical Announces Resolution of Warning Letter (GlobeNewswire) +5.12% +9.65%
Feb-12-25 10:00AM	Outset Medical, Inc. (OM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Feb-03-25 09:00AM	Outset Medical to Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, February 19, 2025 (GlobeNewswire)
Jan-08-25 09:00AM	Outset Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -11.22%
Jan-07-25 05:29AM	Outset Medical to pay down debt after raising nearly $300M (MedTech Dive) -13.39%
Jan-06-25 08:30AM	Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors (GlobeNewswire) -9.29%
Nov-15-24 09:00AM	Outset Medical to Present at the 2024 Stifel Healthcare Conference (GlobeNewswire) -8.01%
Nov-11-24 10:05AM	Outset Medical (OM) Slipped on Earnings Miss and Reduced Guidance (Insider Monkey) +11.24%
Nov-07-24 04:00PM	Outset Medical Inc (OM) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com) +25.18%
Nov-06-24 05:25PM	Outset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:02PM	Outset Medical Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-05-24 08:09AM	Outset Medical Inc (OM) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-23-24 04:05PM	New Research Highlights Improvements in Quality of Life and Caregiver Experience for Home Hemodialysis Patients Using Tablo (GlobeNewswire) -6.06%
09:00AM	Outset Medical to Report Third Quarter 2024 Financial Results on Wednesday, November 6, 2024 (GlobeNewswire)
Oct-18-24 04:25AM	Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman (Newsfile)
Oct-16-24 06:56PM	Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman (GlobeNewswire) -7.94%
Oct-14-24 01:27PM	Shareholders of Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights OM (GlobeNewswire)
Oct-11-24 06:45AM	Shareholders of Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM (PR Newswire)
Sep-27-24 08:26AM	Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman (GlobeNewswire) +16.12%
Sep-23-24 03:57PM	Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman (GlobeNewswire) -10.12%
Sep-20-24 09:13AM	Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman (GlobeNewswire)
Sep-17-24 05:45AM	Outset Medical, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM (PR Newswire)
Sep-13-24 05:45AM	Outset Medical, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM (PR Newswire) +17.67%
Sep-12-24 01:23AM	Analysis of AMERIPRISE FINANCIAL INC's Recent Trade in Outset Medical Inc (GuruFocus.com) -11.69%
01:14AM	Morgan Stanley's Strategic Reduction in Outset Medical Inc Shares (GuruFocus.com)
01:08AM	JPMorgan Chase & Co's Strategic Reduction in Outset Medical Inc (GuruFocus.com)
Sep-11-24 03:44PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (Newsfile)
Sep-09-24 04:10PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (GlobeNewswire)
Sep-06-24 01:47PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (GlobeNewswire)
Sep-04-24 03:23PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (Newsfile)
Sep-03-24 11:57AM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (GlobeNewswire)
Aug-31-24 05:52PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (GlobeNewswire)
Aug-26-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Paragon 28, BrightSpring, Outset, and NuScale and Encourages Investors to Contact the Firm (GlobeNewswire) -5.28%
Aug-07-24 06:35PM	Outset Medical, Inc. (OM) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -68.53%
04:03PM	Outset Medical Reports Second Quarter 2024 Financial Results (Business Wire)
Jul-31-24 10:01AM	Will Outset Medical, Inc. (OM) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jul-24-24 09:00AM	Outset Medical to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 (Business Wire) -5.65%
Jul-01-24 06:00AM	3 MedTech Stocks to Buy for Healthy Gains (InvestorPlace)
Jun-10-24 12:00PM	Outset Medical (OM) Upgraded to Buy: What Does It Mean for the Stock? (Zacks) -8.44%
Jun-03-24 04:05PM	Outset Medical to Present at the Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire)
May-13-24 06:59AM	Morgan Stanley Lowers Price Target on Outset Medical to $4.50 From $5.50, Keeps Equalweight Rating (MT Newswires)
May-10-24 03:48PM	Outset Medical Inc (OM) Q1 2024 Earnings: Misses Revenue Estimates and Widens Losses (GuruFocus.com) -6.12%
May-09-24 03:44PM	Outset Medical, Inc. (NASDAQ:OM) Q1 2024 Earnings Call Transcript (Insider Monkey) -20.82%
09:42AM	Q1 2024 Outset Medical Inc Earnings Call (Thomson Reuters StreetEvents)
03:57AM	Outset Medical Inc (OM) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ... (GuruFocus.com)
May-08-24 08:58PM	OM Stock Earnings: Outset Medical Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) +8.97%
05:45PM	Outset Medical, Inc. (OM) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:02PM	Outset Medical Reports First Quarter 2024 Financial Results (Business Wire)
May-06-24 08:48AM	Outset Medical Receives US FDA 510(k) Clearance for TabloCart With Prefiltration -- Shares Surge 13% Pre-Bell (MT Newswires) +20.70%
08:00AM	Outset Medical's TabloCart with Prefiltration Receives FDA 510(k) Clearance (Business Wire)
May-03-24 09:43AM	Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-01-24 04:30PM	Outset Medical to Present at Upcoming Investor Conferences (Business Wire) +12.65% +5.26%
Apr-19-24 08:30AM	Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 (Business Wire)

Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Drexler Karen	Director	Dec 01 '25	Sale	4.37	1,548	6,765	10,650	Dec 02 05:39 PM
Trigg Leslie	Chair and CEO	Nov 17 '25	Sale	4.60	916	4,214	121,412	Nov 18 04:37 PM
Nash Marc	EVP Operations R&D & Service	Nov 17 '25	Sale	4.60	247	1,136	48,268	Nov 18 04:33 PM
Brottem John L.	General Counsel	Nov 17 '25	Sale	4.60	388	1,785	46,495	Nov 18 04:28 PM
Nash Marc	Officer	Nov 17 '25	Proposed Sale	4.60	247	1,136		Nov 17 06:48 PM
Trigg Leslie	Officer	Nov 17 '25	Proposed Sale	4.60	916	4,214		Nov 17 06:45 PM
Brottem John L.	Officer	Nov 17 '25	Proposed Sale	4.60	388	1,785		Nov 17 06:43 PM
Trigg Leslie	Chair and CEO	Aug 15 '25	Sale	12.88	904	11,644	122,328	Aug 18 04:05 PM
Nash Marc	SVP Operations and R&D	Aug 15 '25	Sale	12.88	243	3,130	42,898	Aug 18 04:01 PM
Brottem John L.	General Counsel	Aug 15 '25	Sale	12.88	383	4,933	46,883	Aug 18 04:00 PM
Trigg Leslie	Officer	Aug 15 '25	Proposed Sale	12.88	904	11,644		Aug 15 07:57 PM
Brottem John L.	Officer	Aug 15 '25	Proposed Sale	12.88	383	4,933		Aug 15 07:53 PM
Nash Marc	Officer	Aug 15 '25	Proposed Sale	12.88	243	3,130		Aug 15 07:48 PM
Trigg Leslie	Chair and CEO	May 15 '25	Sale	17.80	935	16,643	58,129	May 16 05:24 PM
Nash Marc	SVP Operations and R&D	May 15 '25	Sale	17.82	252	4,491	13,465	May 16 05:22 PM
Brottem John L.	General Counsel	May 15 '25	Sale	17.82	396	7,057	11,273	May 16 05:21 PM
Ahmed Nabeel	Chief Financial Officer	May 15 '25	Sale	17.81	584	10,401	16,096	May 16 05:20 PM
Ahmed Nabeel	Officer	May 15 '25	Proposed Sale	17.82	584	10,405		May 15 06:07 PM
Trigg Leslie	Officer	May 15 '25	Proposed Sale	17.80	935	16,646		May 15 05:57 PM
Brottem John L.	Officer	May 15 '25	Proposed Sale	17.82	396	7,058		May 15 05:48 PM
Nash Marc	Officer	May 15 '25	Proposed Sale	17.82	252	4,490		May 15 05:48 PM
Trigg Leslie	Chair and CEO	Feb 18 '25	Sale	0.90	14,611	13,150	880,969	Feb 19 04:30 PM
Nash Marc	SVP Operations and R&D	Feb 18 '25	Sale	0.90	4,204	3,784	200,764	Feb 19 04:29 PM
Brottem John L.	General Counsel	Feb 18 '25	Sale	0.90	6,145	5,530	175,043	Feb 19 04:26 PM
Ahmed Nabeel	Chief Financial Officer	Feb 18 '25	Sale	0.90	8,659	7,793	250,210	Feb 19 04:23 PM
Trigg Leslie	Officer	Feb 18 '25	Proposed Sale	0.90	14,611	13,150		Feb 18 07:18 PM
Nash Marc	Officer	Feb 18 '25	Proposed Sale	0.90	4,204	3,784		Feb 18 06:54 PM
Brottem John L.	Officer	Feb 18 '25	Proposed Sale	0.90	6,145	5,530		Feb 18 06:52 PM
Ahmed Nabeel	Officer	Feb 18 '25	Proposed Sale	0.90	8,659	7,793		Feb 18 06:51 PM
Trigg Leslie	Chair and CEO	Jan 21 '25	Sale	0.80	65,236	52,189	895,580	Jan 22 06:05 PM
Nash Marc	SVP Operations and R&D	Jan 21 '25	Sale	0.80	23,221	18,577	204,968	Jan 22 06:04 PM
Brottem John L.	General Counsel	Jan 21 '25	Sale	0.80	32,930	26,344	181,188	Jan 22 06:03 PM
Ahmed Nabeel	Chief Financial Officer	Jan 21 '25	Sale	0.80	34,288	27,430	258,869	Jan 22 06:02 PM
Trigg Leslie	Officer	Jan 21 '25	Proposed Sale	0.80	65,236	52,189		Jan 21 06:13 PM
Nash Marc	Officer	Jan 21 '25	Proposed Sale	0.80	23,221	18,577		Jan 21 06:10 PM
Brottem John L.	Officer	Jan 21 '25	Proposed Sale	0.80	32,930	26,344		Jan 21 06:09 PM
Ahmed Nabeel	Officer	Jan 21 '25	Proposed Sale	0.80	34,288	27,430		Jan 21 06:06 PM
Trigg Leslie	Chair and CEO	Jan 13 '25	Sale	0.81	33,227	26,914	861,397	Jan 13 06:51 PM
Nash Marc	SVP Operations and R&D	Jan 13 '25	Sale	0.81	15,011	12,159	222,291	Jan 13 06:36 PM
Brottem John L.	General Counsel	Jan 13 '25	Sale	0.81	20,492	16,599	205,028	Jan 13 06:34 PM
Ahmed Nabeel	Chief Financial Officer	Jan 13 '25	Sale	0.81	29,031	23,515	279,901	Jan 13 06:32 PM
Trigg Leslie	Officer	Jan 13 '25	Proposed Sale	0.81	33,227	26,914		Jan 13 06:28 PM
Nash Marc	Officer	Jan 13 '25	Proposed Sale	0.81	15,011	12,159		Jan 13 06:20 PM
Brottem John L.	Officer	Jan 13 '25	Proposed Sale	0.81	20,492	16,599		Jan 13 05:59 PM
Ahmed Nabeel	Officer	Jan 13 '25	Proposed Sale	0.81	29,031	23,515		Jan 13 05:46 PM
Trigg Leslie	Chair and CEO	Jan 07 '25	Sale	1.29	10,227	13,193	894,624	Jan 07 07:32 PM
Nash Marc	SVP Operations and R&D	Jan 07 '25	Sale	1.29	720	929	237,302	Jan 07 07:28 PM
Brottem John L.	General Counsel	Jan 07 '25	Sale	1.29	1,572	2,028	225,520	Jan 07 07:26 PM
Ahmed Nabeel	Chief Financial Officer	Jan 07 '25	Sale	1.29	1,835	2,367	308,932	Jan 07 07:24 PM
Trigg Leslie	Officer	Jan 07 '25	Proposed Sale	1.29	10,227	13,193		Jan 07 07:04 PM
Nash Marc	Officer	Jan 07 '25	Proposed Sale	1.29	720	929		Jan 07 06:55 PM
Brottem John L.	Officer	Jan 07 '25	Proposed Sale	1.29	1,572	2,028		Jan 07 06:27 PM
Ahmed Nabeel	Officer	Jan 07 '25	Proposed Sale	1.29	1,835	2,367		Jan 07 06:07 PM

Open in Screener

RMD

Resmed Inc

Dec 03 • 02:25PM ET

250.93

+0.08 0.03 %

Healthcare • Medical Instruments & Supplies • USA • NYSE

Peers: EW BAX BDX ZBH VNT IART TFX COO HSIC XRAY

| Held by: VTI VOO VO VUG IVV SPY VOT XLV VIG IHI

Index	S&P 500	P/E	25.68	EPS (ttm)	9.77	Insider Own	0.63%	Shs Outstand	145.94M	Perf Week	-1.90%
Market Cap	36.63B	Forward P/E	20.76	EPS next Y	12.09	Insider Trans	-7.66%	Shs Float	145.04M	Perf Month	0.80%
Enterprise Value	36.08B	PEG	2.26	EPS next Q	2.72	Inst Own	65.86%	Short Float	7.34%	Perf Quarter	-8.36%
Income	1.44B	P/S	6.97	EPS this Y	14.42%	Inst Trans	0.63%	Short Ratio	10.01	Perf Half Y	0.40%
Sales	5.26B	P/B	5.98	EPS next Y	10.64%	ROA	18.52%	Short Interest	10.65M	Perf YTD	9.72%
Book/sh	41.94	P/C	26.32	EPS next 5Y	11.38%	ROE	25.41%	52W High	293.81 -14.59%	Perf Year	0.77%
Cash/sh	9.54	P/FCF	20.71	EPS past 3/5Y	21.50% 17.37%	ROIC	21.53%	52W Low	199.92 25.52%	Perf 3Y	11.26%
Dividend Est.	2.43 (0.97%)	EV/EBITDA	18.02	Sales past 3/5Y	12.88% 11.72%	Gross Margin	59.21%	Volatility	2.60% 2.46%	Perf 5Y	21.79%
Dividend TTM	2.26 (0.90%)	EV/Sales	6.86	EPS Y/Y TTM	29.56%	Oper. Margin	33.52%	ATR (14)	6.22	Perf 10Y	324.66%
Dividend Ex-Date	Nov 13, 2025	Quick Ratio	2.13	Sales Y/Y TTM	9.36%	Profit Margin	27.35%	RSI (14)	46.44	Recom	1.86
Dividend Gr. 3/5Y	8.06% 6.33%	Current Ratio	2.89	EPS Q/Q	12.47%	SMA20	0.45%	Beta	0.87	Target Price	301.22
Payout	22.30%	Debt/Eq	0.14	Sales Q/Q	9.07%	SMA50	-3.65%	Rel Volume	0.25	Prev Close	250.85
Employees	10600	LT Debt/Eq	0.09	Earnings	Oct 30 AMC	SMA200	-0.65%	Avg Volume	1.06M	Price	250.93
IPO	Jun 02, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.32% 0.19%	Trades		Volume	205,882	Change	0.03%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-18-25	Initiated	Citigroup	Buy	$330
Sep-02-25	Upgrade	CLSA	Hold → Outperform
Jul-15-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$294
Mar-19-25	Initiated	Morgan Stanley	Overweight	$280
Mar-19-25	Initiated	Morgan Stanley	Overweight
Jan-16-25	Initiated	Goldman	Buy
Jan-10-25	Initiated	Piper Sandler	Neutral	$252
Dec-13-24	Initiated	Stifel	Hold	$250
Sep-24-24	Initiated	Robert W. Baird	Outperform	$280
Sep-18-24	Downgrade	Wolfe Research	Peer Perform → Underperform	$180
Sep-04-24	Downgrade	Needham	Buy → Hold
Jun-25-24	Downgrade	Oppenheimer	Outperform → Perform
Jun-24-24	Downgrade	Citigroup	Buy → Neutral
Feb-06-24	Resumed	KeyBanc Capital Markets	Overweight	$227
Oct-27-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$180 → $169
Oct-12-23	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$273 → $202
Oct-09-23	Upgrade	JP Morgan	Neutral → Overweight	$210 → $170
Sep-29-23	Downgrade	Wolfe Research	Outperform → Peer Perform
Sep-06-23	Upgrade	Needham	Hold → Buy	$180
Sep-05-23	Downgrade	UBS	Buy → Neutral	$265 → $170

Show Previous Ratings

Today 08:14AM	Should You Continue to Hold RMD Stock in Your Portfolio? (Zacks)
Dec-01-25 06:03AM	1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds (StockStory)
Nov-20-25 07:10AM	Are Wall Street Analysts Predicting ResMed Stock Will Climb or Sink? (Barchart)
Nov-17-25 05:11AM	Resmed CEO Mick Farrell on new technologies, tariffs and AI (MedTech Dive)
Nov-12-25 02:00PM	Could GLP-1 Drugs Make ResMed's CPAP Machines Obsolete? (Motley Fool)
04:37PM	Loading…
Nov-11-25 04:37PM	Top Stock Reports for Exxon Mobil, Home Depot & NextEra Energy (Zacks)
Nov-06-25 12:35AM	ResMed's Q3 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Oct-31-25 08:47AM	RMD Q3 Deep Dive: ResMed Launches New Mask Platform and Invests in U.S. Operations (StockStory)
08:22AM	Resmed Stock Up on Q1 Earnings & Revenue Beat, Margins Expand (Zacks)
12:17AM	Analyst Report: ResMed Inc. (Morningstar Research)
Oct-30-25 11:01PM	ResMed Inc (RMD) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations (GuruFocus.com)
08:18PM	Analyst Report: ResMed Inc. (Morningstar Research)
05:30PM	Compared to Estimates, ResMed (RMD) Q1 Earnings: A Look at Key Metrics (Zacks)
05:15PM	ResMed (RMD) Q1 Earnings and Revenues Beat Estimates (Zacks)
04:17PM	ResMed: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Loading…
04:15PM	ResMed (NYSE:RMD) Reports Q3 In Line With Expectations (StockStory)
04:05PM	Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026 (GlobeNewswire)
Oct-29-25 09:15AM	Seeking Clues to ResMed (RMD) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
Oct-28-25 11:03PM	ResMed (RMD) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-27-25 10:33AM	Do Options Traders Know Something About ResMed Stock We Don't? (Zacks)
Oct-24-25 12:45AM	1 Healthcare Stock to Research Further and 2 We Ignore (StockStory)
Oct-23-25 10:00AM	ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-22-25 05:57PM	ResMed Inc. (RMD): A Bull Case Theory (Insider Monkey)
01:25PM	GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring (Zacks)
Oct-21-25 10:06AM	HIMS Stock Declines Despite Launch of New Specialty in Women's Health (Zacks)
Oct-20-25 11:46AM	Zacks.com featured highlights include Stryker, NVIDIA, ResMed and Ralph Lauren (Zacks)
09:45AM	Here's Why ResMed (RMD) is a Strong Growth Stock (Zacks)
Oct-17-25 06:42PM	Top Analyst Reports for Home Depot, Boeing & Progressive (Zacks)
10:49AM	4 GARP Stocks That Investors Can Scoop Up for Maximum Returns (Zacks)
Oct-15-25 01:56PM	GEHC Stock Up Following New Launch to Streamline Perinatal Workflow (Zacks)
08:40AM	Loading…
08:40AM	Abbott (ABT) Q3 Earnings Meet Estimates (Zacks)
Oct-13-25 01:14PM	BD Stock Down Despite Making Progress in the Treatment of PAD Lesions (Zacks)
05:47AM	Zacks.com featured highlights include ResMed, Safran, Pentair, Casey's and Leonardo (Zacks)
Oct-10-25 01:12PM	BD Stock Down Despite Tie-Up to Boost Single-Cell Sequencing Workflow (Zacks)
10:32AM	5 Low-Leverage Stocks to Buy as Market Takes a Tumble (Zacks)
Oct-09-25 04:05PM	Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025 (GlobeNewswire)
08:15AM	Neogen (NEOG) Q1 Earnings Lag Estimates (Zacks)
Oct-08-25 12:44PM	PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell (Zacks)
Oct-07-25 08:04AM	What to Expect From ResMed's Next Quarterly Earnings Report (Barchart)
Oct-02-25 09:45AM	Why ResMed (RMD) is a Top Growth Stock for the Long-Term (Zacks)
09:10AM	Nyxoah Expands in the Middle East to Provide Wider Access to Genio (Zacks)
Sep-25-25 10:07AM	Zacks.com featured highlights include GE Aerospace, ResMed, Vertiv and National Fuel Gas (Zacks)
Sep-24-25 09:32AM	Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns (Zacks)
Sep-18-25 08:52AM	Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring (Zacks)
Sep-16-25 04:05PM	Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025 (GlobeNewswire)
Sep-15-25 02:07AM	How Is ResMed's Stock Performance Compared to Other Healthcare Stocks? (Barchart)
Sep-12-25 09:45AM	Here's Why ResMed (RMD) is a Strong Growth Stock (Zacks)
Sep-11-25 11:32PM	Q2 Earnings Outperformers: ResMed (NYSE:RMD) And The Rest Of The Patient Monitoring Stocks (StockStory)
11:12AM	ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress (Insider Monkey)
Sep-10-25 06:00PM	ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know (StockStory)
Sep-03-25 04:15PM	Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority (GlobeNewswire)
08:51AM	Is it Worth Retaining ResMed Stock in Your Portfolio Now? (Zacks)
Aug-28-25 12:01AM	3 Reasons Investors Watch ResMed (RMD) (StockStory)
Aug-27-25 09:45AM	Here's Why ResMed (RMD) is a Strong Growth Stock (Zacks)
09:00AM	Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds (GlobeNewswire)
Aug-26-25 08:57AM	Is Wall Street Bullish or Bearish on ResMed Stock? (Barchart)
Aug-21-25 02:03PM	Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating (Investor's Business Daily)
09:00AM	Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs (GlobeNewswire)
Aug-20-25 12:33AM	1 Healthcare Stock Worth Investigating and 2 Facing Challenges (StockStory)
Aug-18-25 04:15PM	Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio (GlobeNewswire)
Aug-15-25 10:10AM	Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea (Zacks)
Aug-13-25 09:50AM	Why ResMed (RMD) is a Top Momentum Stock for the Long-Term (Zacks)
Aug-12-25 11:36PM	The Top 5 Analyst Questions From ResMed's Q2 Earnings Call (StockStory)
11:20PM	RMD Q2 Deep Dive: Margin Expansion and Product Innovation Drive Outperformance (StockStory)
Aug-11-25 12:30PM	[Latest] Global High Flow Nasal Cannula Market Size/Share Worth USD 5.9 Billion by 2034 at a 5.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
09:45AM	Why ResMed (RMD) is a Top Growth Stock for the Long-Term (Zacks)
08:30AM	Here's How Much You'd Have If You Invested $1000 in ResMed a Decade Ago (Zacks)
Aug-08-25 01:17PM	The Stock Market Gains Despite Noisy Week. Call It Complacency-or the Right Thing to Do. (Barrons.com)
Aug-04-25 04:04AM	Ventilators Company Evaluation Report 2025 - ResMed, Getinge, and Philips Lead the Ventilator Market Through Innovation, Strong Global Presence, and Strategic Use of Technology and Partnerships (GlobeNewswire)
Aug-01-25 01:00PM	Experity Appoints Bobby Ghoshal as President and Chief Operating Officer (PR Newswire)
12:25PM	ResMed (RMD) Stock Is Up, What You Need To Know (StockStory)
10:24AM	Analyst Report: ResMed Inc. (Morningstar Research)
07:51AM	Resmed Q4 Earnings & Revenues Beat Estimates, Stock Up, Margins Climb (Zacks)
03:34AM	ResMed Inc (RMD) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Acquisitions (GuruFocus.com)
Jul-31-25 06:00PM	Here's What Key Metrics Tell Us About ResMed (RMD) Q4 Earnings (Zacks)
05:20PM	ResMed (RMD) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
05:07PM	ResMed (NYSE:RMD) Surprises With Q2 Sales (StockStory)
04:19PM	ResMed: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025 (GlobeNewswire)
Jul-30-25 08:50AM	Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings (Zacks)
06:08AM	Spot Outliers Like ResMed Early with Money Flows (FX Empire)
Jul-29-25 11:08PM	ResMed (RMD) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
10:00AM	Earnings Preview: Evolus, Inc. (EOLS) Q2 Earnings Expected to Decline (Zacks)
Jul-24-25 12:10PM	Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:49AM	Labcorp Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market (Zacks)
10:00AM	ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
08:30AM	If You Invested $1000 in ResMed a Decade Ago, This is How Much It'd Be Worth Now (Zacks)
08:04AM	Here's What to Expect From ResMed's Next Earnings Report (Barchart)
Jul-23-25 11:59AM	Boston Scientific Beats on Q2 Earnings, Raises 2025 View, Stock Up (Zacks)
09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
09:15AM	ResMed Inc. (RMD) Hit a 52 Week High, Can the Run Continue? (Zacks)
Jul-22-25 08:39AM	Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock Rises (Zacks)
Jul-18-25 10:22AM	Buy These 5 Low-Leverage Stocks Amid Impressive Retail Sales Data (Zacks)
Jul-17-25 01:00AM	This Pick Withstood the GLP-1 Challenge. Stick With the Stock. (Barrons.com)
Jul-16-25 09:40AM	Is Akebia Therapeutics (AKBA) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jul-15-25 12:04AM	2 Reasons to Watch RMD and 1 to Stay Cautious (StockStory)
Jul-09-25 02:33PM	Semler Scientific Stock Gets Relative Strength Rating Upgrade (Investor's Business Daily)
12:35AM	2 S&P 500 Stocks with Promising Prospects and 1 to Steer Clear Of (StockStory)
Jul-01-25 04:05PM	Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025 (GlobeNewswire)

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rider Michael J	Global General Counsel	Dec 01 '25	Sale	244.16	50	12,208	9,791	Dec 02 04:27 PM
Sandercock Brett	Chief Financial Officer	Dec 01 '25	Sale	244.16	1,000	244,160	87,495	Dec 02 04:23 PM
Sandercock Brett	Officer	Dec 01 '25	Proposed Sale	244.16	1,000	244,160		Dec 01 12:11 PM
Rider Michael J	Officer	Dec 01 '25	Proposed Sale	244.16	50	12,208		Dec 01 12:08 PM
De Witte Jan	Director	Nov 25 '25	Sale	255.00	2,055	524,025	4,261	Nov 26 02:40 PM
De Witte Jan	Director	Nov 25 '25	Proposed Sale	255.00	2,055	524,025		Nov 25 03:22 PM
FARRELL PETER C	Director	Nov 14 '25	Option Exercise	101.64	11,442	1,162,965	77,552	Nov 18 04:59 PM
FARRELL PETER C	Director	Nov 12 '25	Sale	252.05	2,000	504,100	66,110	Nov 13 05:39 PM
De Witte Jan	Director	Nov 11 '25	Sale	250.25	487	121,872	5,319	Nov 13 05:24 PM
Peter C Farrell	Director	Nov 12 '25	Proposed Sale	252.05	2,000	504,100		Nov 12 05:21 PM
De Witte Jan	Director	Nov 11 '25	Proposed Sale	250.25	487	121,872		Nov 12 06:44 AM
Farrell Michael J.	Chairman and CEO	Nov 07 '25	Option Exercise	101.64	8,011	814,238	475,877	Nov 10 07:07 PM
Farrell Michael J.	Chairman and CEO	Nov 07 '25	Sale	249.75	8,011	2,000,773	467,866	Nov 10 07:07 PM
Farrell Michael J.	Officer	Nov 07 '25	Proposed Sale	249.75	8,011	2,000,773		Nov 07 04:12 PM
Sandercock Brett	Chief Financial Officer	Nov 03 '25	Option Exercise	101.64	2,000	203,280	88,745	Nov 04 04:02 PM
Sandercock Brett	Chief Financial Officer	Nov 03 '25	Sale	247.54	3,000	742,620	85,745	Nov 04 04:02 PM
Sandercock Brett	Officer	Nov 03 '25	Proposed Sale	247.54	3,000	742,620		Nov 03 10:25 AM
Farrell Michael J.	Chief Executive Officer	Oct 07 '25	Option Exercise	101.64	8,009	814,035	475,801	Oct 09 11:03 AM
Farrell Michael J.	Chief Executive Officer	Oct 07 '25	Sale	282.85	8,009	2,265,332	467,792	Oct 09 11:03 AM
Farrell Michael J.	Officer	Oct 07 '25	Proposed Sale	282.85	8,009	2,265,332		Oct 07 04:10 PM
Ghoshal Kaushik	Former Officer	Oct 07 '25	Proposed Sale	283.42	4,876	1,381,956		Oct 07 01:49 PM
Sandercock Brett	Chief Financial Officer	Oct 01 '25	Option Exercise	101.64	2,000	203,280	89,745	Oct 03 12:56 PM
Sandercock Brett	Chief Financial Officer	Oct 01 '25	Sale	274.36	3,000	823,080	86,745	Oct 03 12:56 PM
Rider Michael J	Global General Counsel	Oct 01 '25	Sale	274.36	100	27,436	11,327	Oct 02 04:32 PM
Rider Michael J	Officer	Oct 01 '25	Proposed Sale	274.36	100	27,436		Oct 01 11:42 AM
Sandercock Brett	Officer	Oct 01 '25	Proposed Sale	274.36	3,000	823,080		Oct 01 10:34 AM
Farrell Michael J.	Chief Executive Officer	Sep 08 '25	Option Exercise	101.64	8,009	814,035	475,801	Sep 09 04:10 PM
Farrell Michael J.	Chief Executive Officer	Sep 08 '25	Sale	278.14	8,009	2,227,590	467,792	Sep 09 04:10 PM
Farrell Michael J.	Officer	Sep 08 '25	Proposed Sale	278.14	8,009	2,227,591		Sep 08 04:22 PM
Sandercock Brett	Chief Financial Officer	Sep 02 '25	Option Exercise	101.64	2,000	203,280	90,745	Sep 03 05:39 PM
Sandercock Brett	Chief Financial Officer	Sep 02 '25	Sale	270.77	3,000	812,310	87,745	Sep 03 05:39 PM
Sandercock Brett	Officer	Sep 02 '25	Proposed Sale	270.77	3,000	812,310		Sep 02 12:02 PM
Hernandez John	Director	Aug 18 '25	Option Exercise	148.90	2,575	383,418	6,620	Aug 19 01:10 PM
Hernandez John	Director	Aug 18 '25	Sale	287.10	2,575	739,289	4,045	Aug 19 01:10 PM
Hernandez John	Director	Aug 18 '25	Proposed Sale	287.10	2,575	739,289		Aug 18 03:11 PM
Farrell Michael J.	Chief Executive Officer	Aug 07 '25	Option Exercise	101.64	8,009	814,035	463,512	Aug 11 10:45 AM
Farrell Michael J.	Chief Executive Officer	Aug 07 '25	Sale	279.48	8,009	2,238,379	455,503	Aug 11 10:45 AM
Farrell Michael J.	Officer	Aug 07 '25	Proposed Sale	282.83	8,009	2,265,185		Aug 07 11:20 AM
Sandercock Brett	Chief Financial Officer	Aug 01 '25	Option Exercise	101.64	2,000	203,280	86,283	Aug 05 12:16 PM
Sandercock Brett	Chief Financial Officer	Aug 01 '25	Sale	281.90	3,000	845,700	83,283	Aug 05 12:16 PM
Rider Michael J	Global General Counsel	Aug 01 '25	Sale	281.90	50	14,095	8,486	Aug 04 07:55 PM
Rider Michael J	Officer	Aug 01 '25	Proposed Sale	281.90	50	14,095		Aug 01 11:52 AM
Sandercock Brett	Officer	Aug 01 '25	Proposed Sale	281.90	3,000	845,700		Aug 01 11:07 AM
Farrell Michael J.	Chief Executive Officer	Jul 07 '25	Option Exercise	101.64	8,009	814,035	463,512	Jul 09 08:37 AM
Farrell Michael J.	Chief Executive Officer	Jul 07 '25	Sale	256.72	8,009	2,056,076	455,503	Jul 09 08:37 AM
Farrell Michael J.	Officer	Jul 07 '25	Proposed Sale	256.72	8,009	2,056,076		Jul 07 05:21 PM
FARRELL PETER C	Director	Jul 02 '25	Sale	255.49	945	241,438	68,273	Jul 03 12:01 PM
Sandercock Brett	Chief Financial Officer	Jul 01 '25	Option Exercise	101.64	2,883	293,028	88,166	Jul 02 05:53 PM
Sandercock Brett	Chief Financial Officer	Jul 01 '25	Sale	256.99	3,883	997,892	84,283	Jul 02 05:53 PM
FARRELL PETER C	Director	Jul 02 '25	Proposed Sale	264.55	945	250,000		Jul 02 04:15 PM
Rider Michael J	Global General Counsel	Jul 01 '25	Sale	256.99	66	16,961	8,536	Jul 02 03:57 PM
Rider Michael J	Officer	Jul 01 '25	Proposed Sale	256.99	66	16,961		Jul 01 12:40 PM
Sandercock Brett	Officer	Jul 01 '25	Proposed Sale	256.99	3,883	997,892		Jul 01 10:35 AM
Farrell Michael J.	Chief Executive Officer	Jun 09 '25	Option Exercise	101.64	8,009	814,035	463,512	Jun 10 06:35 PM
Farrell Michael J.	Chief Executive Officer	Jun 09 '25	Sale	251.21	8,009	2,011,910	455,503	Jun 10 06:35 PM
Farrell Michael J.	Officer	Jun 09 '25	Proposed Sale	252.00	8,009	2,018,268		Jun 09 10:26 AM
FARRELL PETER C	Director	Jun 04 '25	Sale	247.32	2,000	494,640	69,218	Jun 06 03:22 PM
FARRELL PETER C	Director	Jun 04 '25	Proposed Sale	250.00	2,000	500,000		Jun 04 07:19 PM
Sandercock Brett	Chief Financial Officer	Jun 02 '25	Sale	243.78	1,000	243,780	85,283	Jun 03 05:59 PM
Rider Michael J	Global General Counsel	Jun 02 '25	Sale	243.78	41	9,995	8,870	Jun 03 01:13 PM
Rider Michael J	Officer	Jun 02 '25	Proposed Sale	243.78	41	9,995		Jun 02 01:42 PM
Sandercock Brett	Officer	Jun 02 '25	Proposed Sale	243.78	1,000	243,780		Jun 02 09:58 AM
Sandercock Brett	Chief Financial Officer	May 22 '25	Sale	244.59	3,644	891,286	86,283	May 27 10:24 AM
Sandercock Brett	Officer	May 22 '25	Proposed Sale	244.59	3,644	891,286		May 22 10:25 AM
De Witte Jan	Director	May 20 '25	Sale	243.47	2,000	486,940	5,806	May 22 10:05 AM
De Witte Jan	Director	May 20 '25	Proposed Sale	243.47	2,000	486,940		May 20 11:25 AM
Farrell Michael J.	Chief Executive Officer	May 07 '25	Option Exercise	101.64	8,009	814,035	463,512	May 09 11:01 AM
Farrell Michael J.	Chief Executive Officer	May 07 '25	Sale	243.23	8,009	1,948,003	455,503	May 09 11:01 AM
FARRELL PETER C	Director	May 07 '25	Sale	242.25	2,000	484,500	71,218	May 08 05:38 PM
FARRELL PETER C	Director	May 07 '25	Proposed Sale	250.00	2,000	500,000		May 07 08:12 PM
Farrell Michael J.	Officer	May 07 '25	Proposed Sale	243.23	8,009	1,948,003		May 07 04:14 PM
Sandercock Brett	Chief Financial Officer	Apr 08 '25	Sale	215.58	1,000	215,580	89,864	Apr 10 06:14 PM
Farrell Michael J.	Chief Executive Officer	Apr 07 '25	Option Exercise	101.64	8,009	814,035	463,482	Apr 09 10:52 AM
Farrell Michael J.	Chief Executive Officer	Apr 07 '25	Sale	209.85	8,009	1,680,699	455,472	Apr 09 10:52 AM
Sandercock Brett	Officer	Apr 08 '25	Proposed Sale	215.58	1,000	215,580		Apr 08 09:43 AM
Farrell Michael J.	Officer	Apr 07 '25	Proposed Sale	209.85	8,009	1,680,699		Apr 07 04:15 PM
FARRELL PETER C	Director	Apr 02 '25	Sale	219.74	2,000	439,480	73,218	Apr 04 12:47 PM
Rider Michael J	Global General Counsel	Apr 01 '25	Sale	222.86	64	14,263	8,846	Apr 03 12:59 PM
FARRELL PETER C	Director	Apr 02 '25	Proposed Sale	222.30	2,000	444,600		Apr 02 05:00 PM
Rider Michael J	Officer	Apr 01 '25	Proposed Sale	222.86	64	14,263		Apr 01 11:08 AM
Sandercock Brett	Chief Financial Officer	Mar 10 '25	Sale	230.36	1,000	230,360	90,864	Mar 11 09:56 PM
Ghoshal Kaushik	Chief Commercial Officer, SaaS	Mar 10 '25	Option Exercise	186.53	9,745	1,817,753	19,470	Mar 11 04:19 PM
Ghoshal Kaushik	Chief Commercial Officer, SaaS	Mar 10 '25	Sale	239.31	9,745	2,332,096	9,725	Mar 11 04:19 PM
Farrell Michael J.	Chief Executive Officer	Mar 07 '25	Option Exercise	101.64	8,009	814,035	463,481	Mar 11 11:04 AM
Farrell Michael J.	Chief Executive Officer	Mar 07 '25	Sale	229.20	8,009	1,835,692	455,472	Mar 11 11:04 AM
Ghoshal Kaushik	Officer	Mar 10 '25	Proposed Sale	239.31	9,745	2,332,097		Mar 10 04:42 PM
Sandercock Brett	Officer	Mar 10 '25	Proposed Sale	230.36	1,000	230,360		Mar 10 09:58 AM
Farrell Michael J.	Officer	Mar 07 '25	Proposed Sale	224.43	8,009	1,797,460		Mar 07 12:12 PM
FARRELL PETER C	Director	Mar 05 '25	Sale	227.71	2,000	455,420	75,218	Mar 06 05:40 PM
FARRELL PETER C	Director	Mar 05 '25	Proposed Sale	250.00	2,000	500,000		Mar 05 07:20 PM
Ghoshal Kaushik	Chief Commercial Officer, SaaS	Mar 03 '25	Option Exercise	182.90	9,113	1,666,780	18,838	Mar 04 05:25 PM
Ghoshal Kaushik	Chief Commercial Officer, SaaS	Mar 03 '25	Sale	235.40	9,113	2,145,186	9,725	Mar 04 05:25 PM
Rider Michael J	Global General Counsel	Mar 03 '25	Sale	234.10	64	14,982	8,910	Mar 04 04:51 PM
Ghoshal Kaushik	Officer	Mar 03 '25	Proposed Sale	235.42	9,113	2,145,408		Mar 03 04:40 PM
Rider Michael J	Officer	Mar 03 '25	Proposed Sale	234.10	64	14,982		Mar 03 10:27 AM
Sandercock Brett	Chief Financial Officer	Feb 10 '25	Sale	238.98	1,000	238,980	91,864	Feb 11 12:55 PM
Farrell Michael J.	Chief Executive Officer	Feb 07 '25	Option Exercise	101.64	8,009	814,035	463,481	Feb 11 12:54 PM
Farrell Michael J.	Chief Executive Officer	Feb 07 '25	Sale	236.77	8,009	1,896,307	455,472	Feb 11 12:54 PM
Sandercock Brett	Officer	Feb 10 '25	Proposed Sale	238.98	1,000	238,980		Feb 10 11:31 AM
Farrell Michael J.	Officer	Feb 07 '25	Proposed Sale	236.77	8,009	1,896,307		Feb 07 04:28 PM

Cyber Swan Sale

50% Off Elite

OM

Outset Medical Inc

RMD

Resmed Inc

Upgrade your FINVIZ experience